$240 Million is the total value of HARBOURVEST PARTNERS LLC's 33 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 36.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SWI | Sell | Solarwinds Corp. | $145,253,000 | -49.7% | 7,872,801 | -50.0% | 60.42% | +11.8% |
WORK | Sell | Slack Technologies, Inc. | $15,674,000 | -58.7% | 660,531 | -34.8% | 6.52% | -8.2% |
EVLO | Sell | Evelo Biosciences, Inc. | $10,757,000 | -66.0% | 1,763,505 | -50.0% | 4.47% | -24.5% |
KLDO | Sell | Kaliedo Biosciences, Inc. | $8,789,000 | -67.5% | 1,167,166 | -50.0% | 3.66% | -27.8% |
FNJN | Sell | Finjan Holdings, Inc. | $8,650,000 | -54.7% | 4,303,435 | -50.0% | 3.60% | +0.7% |
RUBY | Sell | Rubius Therapeutics, Inc. | $7,747,000 | -75.0% | 986,878 | -50.0% | 3.22% | -44.5% |
AXLA | Axcella Health, Inc. | $6,956,000 | -39.2% | 1,229,034 | 0.0% | 2.89% | +35.2% | |
LC | Sell | LendingClub Corp. | $6,716,000 | -60.1% | 513,440 | -90.0% | 2.79% | -11.3% |
SMAR | New | Smartsheet, Inc. | $4,898,000 | – | 135,933 | +100.0% | 2.04% | – |
ZUO | Sell | Zuora, Inc. | $3,408,000 | -32.1% | 226,434 | -30.9% | 1.42% | +51.0% |
LOV | New | Spark Networks SEsponsored adr | $2,779,000 | – | 502,576 | +100.0% | 1.16% | – |
PRTS | Sell | U.S. Auto Parts Network, Inc. | $2,289,000 | -38.0% | 1,476,877 | -50.0% | 0.95% | +37.8% |
VCYT | New | Veracyte, Inc. | $2,037,000 | – | 84,875 | +100.0% | 0.85% | – |
RDFN | New | Redfin Corp. | $1,932,000 | – | 114,732 | +100.0% | 0.80% | – |
INOV | Sell | Inovalon Holdings, Inc. | $1,865,000 | -43.5% | 113,807 | -50.0% | 0.78% | +25.6% |
YEXT | Sell | Yext, Inc. | $1,830,000 | -60.5% | 115,147 | -50.0% | 0.76% | -12.1% |
NTNX | Sell | Nutanix, Inc. | $1,546,000 | -88.5% | 58,900 | -88.7% | 0.64% | -74.5% |
SFIX | Sell | Stitchfix, Inc. | $1,281,000 | -69.9% | 66,571 | -50.0% | 0.53% | -33.1% |
RYTM | Sell | Rhythm Pharmaceuticals, Inc. | $1,084,000 | -51.0% | 50,221 | -50.0% | 0.45% | +9.2% |
PS | Sell | PluralSight, Inc. | $891,000 | -87.0% | 53,057 | -76.5% | 0.37% | -71.0% |
CTMX | Sell | Cytomx Therapeutics, Inc. | $584,000 | -67.2% | 79,193 | -50.0% | 0.24% | -27.0% |
CSLT | Sell | Castlight Health, Inc. | $492,000 | -78.2% | 349,070 | -50.0% | 0.20% | -51.4% |
UPWK | New | Upwork, Inc. | $457,000 | – | 34,363 | +100.0% | 0.19% | – |
AR | Sell | Antero Resources LLC | $398,000 | -72.7% | 131,895 | -50.0% | 0.17% | -39.2% |
New | Guardant Health, Inc. | $386,000 | – | 6,053 | +100.0% | 0.16% | – | |
KALA | Sell | Kala Pharmaceuticals, Inc. | $377,000 | -70.2% | 99,186 | -50.0% | 0.16% | -33.8% |
PTI | Sell | Proteostasis Therapeutics, Inc. | $372,000 | -56.7% | 440,627 | -50.0% | 0.16% | -3.7% |
RVNC | Sell | Revance Therapeutics, Inc. | $343,000 | -49.9% | 26,365 | -50.0% | 0.14% | +11.7% |
TRVN | Sell | Trevena, Inc. | $226,000 | -53.1% | 233,850 | -50.0% | 0.09% | +4.4% |
EPZM | Sell | Epizyme, Inc. | $145,000 | -59.0% | 14,098 | -50.0% | 0.06% | -9.1% |
CRCM | Sell | Care.com, Inc. | $137,000 | -52.4% | 13,115 | -50.0% | 0.06% | +5.6% |
METC | Sell | Ramaco Resources, Inc. | $56,000 | -65.0% | 14,951 | -50.0% | 0.02% | -23.3% |
HNRG | Sell | Hallador Energy Resources, Inc. | $52,000 | -64.4% | 14,270 | -45.3% | 0.02% | -18.5% |
DBX | Exit | Dropbox, Inc. | $0 | – | -30,618 | -100.0% | -0.14% | – |
NPTN | Exit | NeoPhotonics Corp. | $0 | – | -227,172 | -100.0% | -0.18% | – |
EYE | Exit | National Vision, Inc. | $0 | – | -45,384 | -100.0% | -0.26% | – |
TENB | Exit | Tenable Network Security, Inc. | $0 | – | -87,326 | -100.0% | -0.47% | – |
NSTG | Exit | Nanostring Technologies, Inc. | $0 | – | -111,472 | -100.0% | -0.63% | – |
SNAP | Exit | Snap, Inc. | $0 | – | -592,824 | -100.0% | -1.59% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Wayfair, Inc. | 25 | Q3 2023 | 83.5% |
Trevena, Inc. | 25 | Q4 2021 | 1.2% |
Finjan Holdings, Inc. | 23 | Q2 2020 | 18.5% |
Zuora, Inc. | 21 | Q3 2023 | 3.4% |
Evelo Biosciences, Inc. | 20 | Q1 2023 | 26.3% |
CytomX Therpeutics, Inc. | 19 | Q4 2021 | 2.3% |
LendingClub Corp. | 18 | Q3 2019 | 11.9% |
Rubius Therapeutics, Inc. | 18 | Q4 2022 | 21.4% |
Solarwinds Corp. | 17 | Q4 2022 | 60.4% |
Axcella Health, Inc. | 17 | Q2 2023 | 6.7% |
View HARBOURVEST PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
SolarWinds Corp | February 14, 2022 | 3,719,600 | 2.3% |
N-able, Inc. | December 20, 2021 | 3,719,600 | 2.1% |
OncoMed Pharmaceuticals Inc | February 14, 2019 | 1,901,106 | 4.9% |
Wayfair Inc. | February 16, 2016 | 2,115,296 | 4.6% |
ENVIVIO INC | February 13, 2013 | 3,639,939 | 13.5% |
NETWORK ENGINES INCSold out | February 13, 2013 | 0 | 0.0% |
VOCALTEC COMMUNICATIONS LTD | August 06, 2010 | 243,689 | 2.1% |
CERAGON NETWORKS LTDSold out | July 26, 2007 | 0 | 0.0% |
VISTAPRINT LTDSold out | February 14, 2007 | 0 | 0.0% |
VOCALTEC COMMUNICATIONS LTD | May 26, 2006 | 1,218,444 | 24.4% |
View HARBOURVEST PARTNERS LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
40-APP | 2024-04-24 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR/A | 2022-05-26 |
13F-HR | 2022-05-13 |
View HARBOURVEST PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.